Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:February 17, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:February 17, 2020Completed
Condition(s):Covid19; Diabetes Mellitus, Type 2; CKDLast Updated:September 28, 2021Unknown status
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:March 2, 2021Completed
Condition(s):Diabetes MellitusLast Updated:August 2, 2016Completed
Condition(s):Overweight; Sustainability; Food; Microbiota; HabitsLast Updated:January 27, 2023Completed
Condition(s):ObesityLast Updated:August 15, 2012Completed
Condition(s):Nutrition Aspect of CancerLast Updated:October 12, 2018Unknown status
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:July 20, 2022Completed
Condition(s):Lower Urinary Tract SymptomsLast Updated:November 14, 2018Unknown status
Condition(s):Cardiomyopathies; Insulin Resistance; Non-ischemic Cardiomyopathy; Cardiac Fibrosis; DiabetesLast Updated:March 24, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.